• Produktbild: Neurobiology of Cerebrospinal Fluid 1
  • Produktbild: Neurobiology of Cerebrospinal Fluid 1

Neurobiology of Cerebrospinal Fluid 1

97,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

19.03.2012

Abbildungen

XXVIII, 768 p.

Herausgeber

James H. Wood

Verlag

Springer Us

Seitenzahl

768

Maße (L/B/H)

25,4/20,3/4,3 cm

Gewicht

1681 g

Auflage

Softcover reprint of the original 1st ed. 1980

Sprache

Englisch

ISBN

978-1-4684-1041-9

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

19.03.2012

Abbildungen

XXVIII, 768 p.

Herausgeber

James H. Wood

Verlag

Springer Us

Seitenzahl

768

Maße (L/B/H)

25,4/20,3/4,3 cm

Gewicht

1681 g

Auflage

Softcover reprint of the original 1st ed. 1980

Sprache

Englisch

ISBN

978-1-4684-1041-9

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Neurobiology of Cerebrospinal Fluid 1
  • Produktbild: Neurobiology of Cerebrospinal Fluid 1
  • 1: Physiology, Pharmacology, and Dynamics of Cerebrospinal Fluid.- 2: Role of Cyclic AMP in Cerebrospinal Fluid Production.- 3: Chemical Alterations of Cerebrospinal Fluid Acting on Respiratory and Circulatory Control Systems.- 4: Neurochemical Aspects of Blood-Brain-Cerebrospinal Fluid Barriers.- 5: Sites of Origin and Cerebrospinal Fluid Concentration Gradients: Neurotransmitters, Their Precursors and Metabolites, and Cyclic Nucleotides.- 6: Daily Fluctuations in Cathecholamines, Monoamine Metabolites, Cyclic AMP, and ?-Aminobutyric Acid.- 7: Technical Aspects of Clinical and Experimental Cerebrospinal Fluid Investigations.- 8: Cerebrospinal Fluid Amine Metabolites and Probenecid Test.- 9: Extracellular Cyclic Nucleotide Metabolism in Human Central Nervous System.- 10: Norepinephrine in Cerebrospinal Fluid: Basic Studies, Effects of Drugs and Disease.- 11: Huntington’s Disease: Biogenic Amines in Cerebrospinal Fluid.- 12: Cerebrospinal Fluid Noradrenergic and Behavioral Alterations Associated with Stimulation and Atrophy of Caudate Nucleus.- 13: Evaluation of Cerebrospinal Fluid ?-Aminobutyric Acid Content in Neurological and Psychiatric Disorders.- 14: Cerebrospinal Fluid ?-Aminobutyric Acid: Correlation with Cerebrospinal Fluid and Blood Constituents and Alterations in Neurological Disorders.- 15: Cerebrospinal Fluid Studies in Parkinson’s Disease: Norepinephrine and ?-Aminobutyric Acid Concentrations.- 16: Neurochemical Alterations in Parkinson’s Disease.- 17: Cerebrospinal Fluid Monoamine Metabolites in Neurological Disorders of Childhood.- 18: Seizure-Induced Metabolic Alterations in Human Cerebrospinal Fluid.- 19: Neurotransmitter, Metabolite, and Cyclic Nucleotide Alterations in Cerebrospinal Fluid of Seizure Patients.- 20: Subarachnoid Hemorrhage.-21: Effects of Subarachnoid Blood and Spasmodic Agents on Cerebral Vasculature.- 22: Response of Extraparenchymal Cerebral Arteries to Biochemical Environment of Cerebrospinal Fluid.- 23: Subarachnoid Erythrocytes and their Contribution to Cerebral Vasospasm.- 24: Neurochemical Alterations in Cerebrospinal Fluid in Cerebral Ischemia and Stroke.- 25: Cerebrospinal Fluid Cyclic Nucleotide Alterations in Traumatic Coma.- 26: Acetylcholine Metabolism in Intracranial and Lumbar Cerebrospinal Fluid and in Blood.- 27: Cerebrospinal Fluid Pressure Dynamics and Brain Metabolism.- 28: Non-Steady-State Measurements of Cerebrospinal Fluid Dynamics: Laboratory and Clinical Applications.- 29: Experimental Studies Relating to Diagnostic Imaging in Disorders of Cerebrospinal Fluid Circulation.- 30: Dynamics of the Cerebrospinal Fluid System as Defined by Cranial Computed Tomography.- 31: Cerebrospinal Fluid Alterations Associated with Central Nervous System Infections.- 32: Penetration of Antimicrobial Agents into Cerebrospinal Fluid: Pharmacokinetic and Clinical Aspects.- 33: Pathophysiology of Cerebrospinal Fluid Immunoglobulins.- 34: Myelin Basic Protein in Cerebrospinal Fluid: Index of Active Demyelination.- 35: Electron-Microscopic Studies on Cerebrospinal Fluid Sediment.- 36: Lymphocyte Subpopulations in Human Cerebrospinal Fluid: Effects of Various Disease States and Immunosuppressive Drugs.- 37: Intrathecal Lymphocyte Infusions: Clinical and Animal Toxicity Studies.- 38: Cerebrospinal Fluid Analysis in Central Nervous System Cancer.- 39: Pharmacology of Antineoplastic Agents in Cerebrospinal Fluid.- 40: Cerebrospinal Fluid Melatonin.- 41: Cerebrospinal Fluid Pituitary Hormone Concentrations in Patients with Pituitary Tumors.- 42: Cerebrospinal Fluid Steroid Hormones.- 43: Cerebrospinal Fluid Vasopressin and Vasotocin in Health and Disease.- 44: Significance and Function of Neuropeptides in Cerebrospinal Fluid.- 45: Endorphins in Cerebrospinal Fluid.- 46: Cerebrospinal Fluid Monoamine Metabolites in Neuropsychiatric Disorders of Childhood.- 47: Cerebrospinal Fluid Studies of Neurotransmitter Function in Manic and Depressive Illness.- 48: Cerebrospinal Fluid Studies in Schizophrenia.- 49: Cerebrospinal Fluid Calcium: Clinical Correlates in Psychiatric and Seizure Disorders.